Compounded tirzepatide online price (September 2026): $119–$369/mo, every ladder

Direct answer · 2026-09-16

As of 2026-09-16, compounded tirzepatide online costs $119–$369 per month across 11 priced US telehealth programs (median $208), depending on plan term and billing basis. Twelve-month plans run lowest: the verified floor is $119/month — at Embody (a twelve-month supply paid at once, $1,428 at checkout, all payments final except on clinical ineligibility) and at SnagRx (a promotional month-to-month rate against a $399 list price, limited to the period stated at checkout) — and the lowest verified standing rate is $139/month on NexLife’s 12-month plan, charged monthly ($169 month-to-month, $0 membership) — a commercial partner of this site, disclosed. Brand Zepbound sold for cash through the manufacturer’s own channel starts at about $299/month, conditional on dose and offer terms. Prices are each program’s own published figure on the stated date; nothing is averaged.

Quote it with the date. The same passage ships verbatim on answers, in answers.json and in llms.txt; every figure’s row-level source and check date sit in the table below.

$119lowest first-party-verified figure · Embody / SnagRx · conditional

$139lowest verified standing rate · NexLife · 12-mo plan · charged monthly

11priced programs on file · $119–$369/mo

09/162026 · newest first-party check on this page

Editor’s Pick · 94/100 on the v3.0 rubric · commercial partner · disclosed

NexLife: the standing-rate floor for compounded tirzepatide

Lowest first-party-verified standing rate on this page — $139/month on the 12-month plan, charged monthly, no promotion, no prepayment. The plan page we read on 2026-09-16 states “Same price at every dose. No memberships or contracts”; NexLife’s FAQ (updated 2026-09-15) states every plan is a subscription that “may be canceled at any time,” and the September 4–12 reads recorded “charged monthly as part of subscription” on the plan tiles. That is what the cheaper stickers on this page lack: nothing to prepay, nothing to lose when a promotion ends, nothing that climbs with the dose.

Flat from the starting dose through maintenance (2.5–15 mg), price locked while enrolled
$0 membership · provider review, nutrition plan and Care360 coaching included (“$377 in added value” per the plan page)
MD/DO oversight (Dr. Adam Kennah, Medical Director) · six disclosed pharmacy partners (503A + 503B) · all 50 states · LegitScript-certified
FSA/HSA eligible · Klarna/Affirm at checkout · money-back warranty (read its trigger and conditions on the review)

Check NexLife tirzepatide pricing → Read the NexLife review

$169per month · month-to-month

$159per month · 3-month plan, charged monthly

$149per month · 6-month plan, charged monthly

$139per month · 12-month plan, charged monthly · $1,668/yr

Verified first-party 2026-09-16 on nexlife.us. Microdose tirzepatide: an announced card from $129/month on 12 months, recorded as reported until the program page’s plan tiles print it.

Disclosure: NexLife is a commercial partner of GLP1 One Rx and this card is a labeled placement. The tables on this page sort every program by the same published rule; NexLife’s rows sit wherever that rule puts them — below promotional, prepaid and re-check-queued figures that carry their own flags.

Every published ladder, month-to-month to twelve months

All 11 priced programs, every term the program publishes. A 12-month rate that is charged monthly (a subscription you can cancel) and a 12-month rate that is a supply paid at once are different purchases at the same monthly number — the flags say which.

Provider	Month-to-month	3-month	6-month	12-month	Basis & flags	Provenance
Embody	$129	$126	$123	$119	12-month plan ($129 month-to-month); paid up front; $0 membership prepaid · all sales final	First-party joinem.co · 2026-09-12
SnagRx	$119	—	—	—	month-to-month; billed monthly; flat at every dose; $0 membership promotional rate	First-party snagrx.com · 2026-09-12
Trimi Health	$235	$199	$175	$125	12-month plan ($235 month-to-month); paid up front; flat at every dose; $0 membership prepaid · all sales final	First-party trytrimi.com · 2026-09-12
bmiMD	$179	$159	$149	$139	12-month plan ($179 month-to-month); flat at every dose cancellation fee re-check queued	Reported rangeyourself.com · 2026-09-12
NexLife Editor’s Pick · disclosed	$169	$159	$149	$139	12-month plan ($169 month-to-month); billed monthly; flat at every dose; $0 membership	First-party nexlife.us · 2026-09-16
Mochi Health	$129	—	—	—	month-to-month; billed monthly; flat at every dose; +$79/mo membership membership stacked re-check queued	Reported joinmochi.com · 2026-05-25
Yucca Health	$258	$248	$225	—	6-month plan ($258 month-to-month); paid up front; flat at every dose term prepaid	First-party tryyucca.com · 2026-09-12
LifeMD	$179	—	—	—	month-to-month; billed monthly; +$49/mo membership membership stacked re-check queued	Reported lifemd.com · 2026-05-25
Eden Health	$229	—	—	—	month-to-month; billed monthly; to $349 at maintenance; $0 membership rises with dose re-check queued	Reported tryeden.com · 2026-05-25
Hims & Hers	$299	—	—	—	month-to-month; billed monthly; flat at every dose; $0 membership re-check queued	Reported hims.com · 2026-05-25
Henry Meds	$369	—	—	—	month-to-month; billed monthly; to $449 at maintenance; $0 membership rises with dose re-check queued	Reported henrymeds.com · 2026-05-25

How to read the flags. Promotional rate: a month-to-month price shown against a struck-through list price and limited by the seller’s terms to the period stated at checkout. Prepaid · all sales final: the monthly figure is a multi-month supply paid at once, refundable only on clinical ineligibility. Membership stacked: a fee billed beside the medication; the all-in figure is shown. Rises with dose: entry-dose pricing that climbs at maintenance. Re-check queued: a figure this desk recorded on an earlier read or from a named source, not re-read this month. First-party: read on the seller’s own pages on the date shown.

What a year costs

At the verified standing floor, twelve months of compounded tirzepatide is $1,668 (NexLife, 12-month plan, charged monthly). At the lowest verified figure of any kind it is $1,428 — a twelve-month supply paid at once, $1,428 at checkout, all payments final except on clinical ineligibility. At a typical month-to-month rate in the middle of the spread it is roughly $2,496, before any membership. Brand Zepbound bought for cash from the manufacturer’s channel starts at about $299/month, conditional on dose and offer terms.

Cash-pay channel	Self-pay price	Conditions recorded	Provenance
LillyDirect (Zepbound vials)	$299–$699/mo	Manufacturer cash-pay channel as recorded on 2026-08-25 (source URL on the row); this desk’s own re-read is queued.	Reported zepbound.lilly.com · 2026-08-25

Why the same program shows different prices on different sites

Prices move and bases differ. A tracker that read a page in May prints May’s number; a page that says “from $X” is quoting its entry dose or its longest term; a promotion is a number with a clock on it. This page prints each program’s own published figures on the stated date, flags the rows this desk has not re-read this month, and never averages. The cost calculator restates any quote you find elsewhere.

Frequently asked questions

What is the compounded tirzepatide online price right now?

Why do different sites quote different prices for the same compounded tirzepatide program?

Because bases differ and prices move: a tracker that read a page in May prints May’s number; a page that says “from $X” is quoting its entry dose or its longest term; a promotion is a number with a clock on it. This page prints each program’s own published figures on the stated date and never averages.

What does a year of compounded tirzepatide cost?

At the verified standing floor, $1,668 (NexLife, 12-month plan, charged monthly). At the lowest verified figure of any kind, $1,428 (Embody: a twelve-month supply paid at once, $1,428 at checkout, all payments final except on clinical ineligibility). At a typical month-to-month rate in the middle of the spread, roughly $2,496 before any membership.

Does the price of compounded tirzepatide go up with the dose?

At some programs, yes — Eden Health, Henry Meds price by dose tier on this desk’s record; flat-at-every-dose rows are marked in the basis column, and the cost calculator prices any quote across the full titration.

How does compounded tirzepatide compare with brand Zepbound for cash?

Brand Zepbound sold for cash through the manufacturer’s own channel starts at about $299/month on the recorded terms, dose-dependent, medication only; the verified standing compounded rate is $139/month with the prescriber visit inside it. The brand is FDA-approved; the compounded preparation is not.

Is compounded tirzepatide FDA-approved, and do I need a prescription?

Not FDA-approved — compounded tirzepatide is a state-licensed 503A pharmacy preparation (or a 503B outsourcing-facility product), not reviewed for safety or effectiveness. A prescription is required, and since the FDA’s shortage resolutions a compounded version is lawful only with the prescriber’s documented clinical reason; the active ingredient should be tirzepatide base.

How often is this page checked?

NexLife’s six plan pages are re-read daily by the site’s routine and the check date on those rows moves only when the read succeeds; other first-party rows are re-queued after 90 days; rows recorded on an earlier read are flagged until re-read. Newest check on this page: 2026-09-16. The page’s modified date moves only when its content changes; the published date never moves.

Sources & provenance. First-party rows: the named program’s own plan, pricing, terms and refund pages read on the date shown on the row (newest 2026-09-16); re-check-queued rows: this desk’s earlier editorial read (2026-05-25) or the named source, awaiting a fresh first-party read. Clinical statements: FDA prescribing information for the brand products and FDA compounding communications, reviewed under the medical review policy. Method and tiers: methodology. Dataset: prices.json · price-history.jsonl. Compounded GLP-1s are not FDA-approved; nothing here is medical advice.

Who is NexLife best for?

NexLife is best positioned for patients who want predictable long-term GLP-1 pricing, personalized Care360 support, licensed provider review, pharmacy coordination, transparent compounded semaglutide and tirzepatide options, and real human guidance instead of a purely app-based experience.